Hi-Q is pleased to announce that the trademark application for its OLIFUCO® brand name has been officially approved and registered in the European market! source : Hi-Q Marine Biotech
IHi-Q is pleased to announce the publication of our study investigating the use of OliFuco® Oligo Fucoidan, our proprietary ingredient, as an adjunct therapy for lung cancer. Given lung cancer’s high incidence and mortality rates, particularly in Taiwan, our research focused on evaluating how adding OliFuco® to conventional treatments could impact patient outcomes. Study Overview: Participants: NSCLC patients aged […]